CRISPR Therapeutics (CRSP) Institutional Ownership $40.72 +0.34 (+0.84%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CRISPR Therapeutics (NASDAQ:CRSP)CurrentInstitutional OwnershipPercentage69.20%Number ofInstitutional Buyers(last 12 months)229TotalInstitutional Inflows(last 12 months)$634.80MNumber ofInstitutional Sellers(last 12 months)110TotalInstitutional Outflows(last 12 months)$243.49M Get CRSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRSP Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now CRISPR Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.7,097$339K0.0%+12.7%0.008% 11/25/2024 Wilmington Savings Fund Society FSB850$40K0.0%N/A0.001% 11/25/2024 Sanctuary Advisors LLC8,317$398K0.0%+17.8%0.010% 11/20/2024 Westside Investment Management Inc.6,442$308K0.1%-13.7%0.008% 11/20/2024 Virtu Financial LLC7,734$363K0.0%-22.2%0.009% 11/18/2024 Arete Wealth Advisors LLC10,376$486K0.0%-3.6%0.012% Get the Latest News and Ratings for CRSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/18/2024 Sunbelt Securities Inc.2,955$139K0.0%+11.3%0.003% 11/16/2024 Geode Capital Management LLC1,008,214$47.38M0.0%+3.6%1.181% 11/15/2024 Main Management ETF Advisors LLC14,744$693K0.0%N/A0.017% 11/15/2024 XTX Topco Ltd30,022$1.41M0.1%+294.0%0.035% 11/15/2024 State Street Corp2,992,988$140.61M0.0%+25.0%3.507% 11/15/2024 Stifel Financial Corp40,237$1.89M0.0%-20.2%0.047% 11/15/2024 Readystate Asset Management LP7,153$336K0.0%N/A0.008% 11/15/2024 Reynders McVeigh Capital Management LLC119,586$5.62M0.3%+4.3%0.140% 11/15/2024 HighTower Advisors LLC38,316$1.79M0.0%-3.4%0.045% 11/15/2024 Benjamin Edwards Inc.32,703$1.54M0.0%+13,640.8%0.038% 11/15/2024 Baker BROS. Advisors LP843,075$39.61M0.4%+743.1%0.988% 11/14/2024 Bellevue Group AG610,000$28.66M0.5%-1.2%0.715% 11/14/2024 Captrust Financial Advisors31,712$1.49M0.0%+32.0%0.037% 11/14/2024 Rockefeller Capital Management L.P.92,867$4.36M0.0%-1.2%0.109% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC676,326$31.77M0.0%-2.5%0.792% 11/13/2024 Freedom Investment Management Inc.8,161$383K0.0%-5.0%0.010% 11/13/2024 BNP Paribas Financial Markets87,956$4.13M0.0%-35.5%0.103% 11/13/2024 FMR LLC2,376,166$111.63M0.0%+1.0%2.784% 11/13/2024 The Manufacturers Life Insurance Company12,477$586K0.0%+1.9%0.015% 11/13/2024 Horizon Kinetics Asset Management LLC10,239$481K0.0%-4.1%0.012% 11/13/2024 Loomis Sayles & Co. L P945,267$44.41M0.1%-6.1%1.108% 11/13/2024 Boston Family Office LLC9,763$459K0.0%+2.2%0.011% 11/13/2024 Bedell Frazier Investment Counselling LLC26,357$1.24M0.3%+0.8%0.031% 11/13/2024 Independent Advisor Alliance7,719$363K0.0%+29.2%0.009% 11/12/2024 SevenBridge Financial Group LLC6,076$285K0.1%+7.5%0.007% 11/12/2024 Charles Schwab Investment Management Inc.724,241$34.03M0.0%+0.9%0.849% 11/8/2024 Darwin Wealth Management LLC925$43K0.0%N/A0.001% 11/8/2024 Advisors Asset Management Inc.9,669$454K0.0%+3.7%0.011% 11/8/2024 Banque Cantonale Vaudoise17,111$804K0.0%-1.5%0.020% 11/7/2024 Swiss National Bank157,600$7.40M0.0%-0.7%0.185% 11/7/2024 Thrivent Financial for Lutherans47,696$2.24M0.0%+1.0%0.056% 11/6/2024 Natixis Advisors LLC10,042$472K0.0%-7.9%0.012% 11/6/2024 Curi RMB Capital LLC46,715$2.20M0.0%+19.4%0.055% 11/6/2024 KBC Group NV2,818$132K0.0%+43.9%0.003% URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now11/6/2024 Bouvel Investment Partners LLC21,703$1.02M0.4%-1.0%0.026% 11/6/2024 Oppenheimer & Co. Inc.34,128$1.60M0.0%+7.8%0.040% 11/5/2024 Aigen Investment Management LP6,335$298K0.1%N/A0.007% 11/5/2024 Sumitomo Mitsui Trust Group Inc.2,968,034$139.44M0.1%-5.8%3.490% 11/5/2024 Baillie Gifford & Co.364,768$17.14M0.0%-10.0%0.429% 11/5/2024 Entropy Technologies LP7,905$371K0.0%-48.7%0.009% 11/4/2024 Venturi Wealth Management LLC1,700$80K0.0%-29.2%0.002% 11/4/2024 State of New Jersey Common Pension Fund D40,341$1.90M0.0%+16.8%0.047% 11/4/2024 Axxcess Wealth Management LLC10,271$483K0.0%+3.3%0.012% 11/2/2024 Privium Fund Management B.V.30,347$1.43M0.4%+11.0%0.036% 11/1/2024 Leavell Investment Management Inc.5,700$268K0.0%-54.9%0.007% 10/31/2024 ARK Investment Management LLC7,498,625$352.29M3.2%-3.6%8.830% 10/29/2024 Van ECK Associates Corp1,546$71K0.0%-98.1%0.002% 10/29/2024 Capital Advisors Inc. OK300,589$14.12M0.3%+8.1%0.354% 10/28/2024 EMC Capital Management3,330$156K0.1%-64.2%0.004% 10/28/2024 US Bancorp DE2,589$122K0.0%-55.5%0.003% 10/28/2024 Congress Asset Management Co.65,768$3.09M0.0%+2.8%0.077% 10/28/2024 HM Payson & Co.2,330$109K0.0%+115.7%0.003% 10/25/2024 SteelPeak Wealth LLC10,183$478K0.0%-35.0%0.012% 10/25/2024 Pinnacle Associates Ltd.3,993$188K0.0%N/A0.005% 10/25/2024 China Universal Asset Management Co. Ltd.16,381$770K0.1%+64.2%0.019% 10/25/2024 SFE Investment Counsel6,312$297K0.1%+8.0%0.007% 10/24/2024 Patriot Financial Group Insurance Agency LLC29,586$1.39M0.2%+7.9%0.035% 10/24/2024 Farrow Financial Inc.19,827$931K0.6%+14.2%0.023% 10/24/2024 Wealth Enhancement Advisory Services LLC30,241$1.42M0.0%-5.2%0.036% 10/24/2024 PFG Investments LLC9,651$453K0.0%-7.3%0.011% 10/24/2024 Arkadios Wealth Advisors11,295$531K0.0%+4.9%0.013% 10/23/2024 Mirae Asset Global Investments Co. Ltd.3,080$146K0.0%+21.5%0.004% 10/23/2024 Allworth Financial LP680$32K0.0%-71.7%0.001% 10/23/2024 Hennion & Walsh Asset Management Inc.40,568$1.91M0.1%+15.9%0.048% 10/22/2024 International Assets Investment Management LLC38,852$1.83M0.0%N/A0.046% 10/22/2024 Private Advisor Group LLC71,747$3.37M0.0%-7.6%0.084% 10/22/2024 Eastern Bank1,500$70K0.0%N/A0.002% 10/22/2024 Sequoia Financial Advisors LLC4,795$225K0.0%-52.4%0.006% 10/18/2024Slow Capital Inc.85,910$4.04M0.6%+8.5%0.101% 10/18/2024Blue Trust Inc.3,844$181K0.0%+158.7%0.005% 10/18/2024Stratos Wealth Advisors LLC5,442$256K0.0%-20.1%0.006% 10/17/2024 Harbour Capital Advisors LLC8,925$405K0.1%-3.8%0.011% 10/16/2024 nVerses Capital LLC5,500$258K0.1%N/A0.006% 10/16/2024 IQ EQ FUND MANAGEMENT IRELAND Ltd13,617$640K0.1%+56.4%0.016% 10/16/2024 Vontobel Holding Ltd.16,957$797K0.0%+3.7%0.020% 10/11/2024 Creative Planning13,671$642K0.0%-7.3%0.016% 10/10/2024 Exchange Traded Concepts LLC19,192$902K0.0%+22.8%0.023% 10/8/2024 CWM LLC19,254$905K0.0%-14.0%0.023% 10/7/2024 Green Alpha Advisors LLC19,158$900K0.7%-2.4%0.023% 10/5/2024 Handelsbanken Fonder AB29,100$1.37M0.0%-71.0%0.034% 10/3/2024 SG Americas Securities LLC25,711$1.21M0.0%-1.8%0.030% 9/5/2024 Sanctuary Advisors LLC7,059$381K0.0%N/A0.008% 8/22/2024 Cetera Investment Advisers26,838$1.45M0.0%-21.3%0.032% 8/21/2024 Granite Bay Wealth Management LLC41,096$2.38M0.1%N/A0.048% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.8/19/2024 B. Riley Wealth Advisors Inc.8,867$479K0.0%-47.3%0.010% 8/16/2024 Sunbelt Securities Inc.2,655$143K0.0%+23.2%0.003% 8/16/2024 Northwestern Mutual Wealth Management Co.4,606$249K0.0%+4.8%0.005% 8/16/2024 Creative Planning14,750$797K0.0%+3.2%0.017% 8/16/2024 Algert Global LLC12,342$667K0.0%+45.0%0.015% 8/15/2024 Susquehanna Portfolio Strategies LLC5,845$316K0.0%-84.3%0.007% 8/15/2024 Scientech Research LLC24,323$1.31M0.3%+181.6%0.029% 8/15/2024 The Manufacturers Life Insurance Company12,246$661K0.0%-39.9%0.014% 8/15/2024 Armistice Capital LLC198,357$10.71M0.1%+3.3%0.234% 8/14/2024 Marshall Wace LLP186,591$10.08M0.0%N/A0.220% (Data available from 1/1/2016 forward) CRSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRSP shares? During the previous two years, 360 institutional investors and hedge funds held shares of CRISPR Therapeutics. The most heavily invested institutionals were Capital International Investors ($534.18M), ARK Investment Management LLC ($352.29M), Nikko Asset Management Americas Inc. ($222.70M), Sumitomo Mitsui Trust Holdings Inc. ($170.21M), State Street Corp ($140.61M), Sumitomo Mitsui Trust Group Inc. ($139.44M), and FMR LLC ($111.63M).Learn more on CRSP's institutional investors. What percentage of CRISPR Therapeutics stock is owned by institutional investors? 69.20% of CRISPR Therapeutics stock is owned by institutional investors. Learn more on CRSP's institutional investor holdings. Which institutional investors have been buying CRISPR Therapeutics stock? Of the 308 institutional investors that purchased CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Capital International Investors ($1.80M), ARK Investment Management LLC ($1.53M), SR One Capital Management LP ($1.05M), Baker BROS. Advisors LP ($743.08K), Marshall Wace LLP ($643.60K), Norges Bank ($617.59K), and State Street Corp ($599.30K). How much institutional buying is happening at CRISPR Therapeutics? Institutional investors have bought a total of 15,198,323 shares in the last 24 months. This purchase volume represents approximately $869.52M in transactions. Which CRISPR Therapeutics major shareholders have been selling company stock? Of the 171 institutional investors that sold CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ARK Investment Management LLC ($1.89M), Sumitomo Mitsui Trust Holdings Inc. ($1.11M), Armistice Capital LLC ($644.01K), Nikko Asset Management Americas Inc. ($487.28K), Allspring Global Investments Holdings LLC ($346.18K), Bellevue Group AG ($288.60K), and Price T Rowe Associates Inc. MD ($264.11K). How much institutional selling is happening at CRISPR Therapeutics? Institutional investors have sold a total of 8,176,985 shares in the last 24 months. This volume of shares sold represents approximately $438.81M in transactions. Related Companies Neurocrine Biosciences Major Shareholders Bio-Techne Major Shareholders Vaxcyte Major Shareholders Qiagen Major Shareholders Exelixis Major Shareholders Repligen Major Shareholders Revolution Medicines Major Shareholders Halozyme Therapeutics Major Shareholders Krystal Biotech Major Shareholders Arcellx Major Shareholders This page (NASDAQ:CRSP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRSP Stock Alerts